Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(14):1124-1125; doi:10.1093/jnci/92.14.1124
© 2000 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 14, 1124-1125, July 19, 2000
© 2000 Oxford University Press


NEWS

Awards, Appointments, Announcements

The American Society for Blood and Marrow Transplantation presented three awards at its annual meeting.

The Lifetime Achievement Award was given to George W. Santos, M.D. Santos founded the Johns Hopkins Bone Marrow Transplantation Program in 1968. Laboratory studies completed early in his career remain key to current understanding of transplantation immunology, graft-versus-host disease, and tolerance.

The ASBMT Public Service Award was awarded to Susan Stewart, founder of the Blood & Marrow Transplant Newsletter and director of the Blood and Marrow Transplantation Network. She also is the author of the popular patient guidebook, Bone Marrow Transplants: A Book of Basics for Patients.

Robert A. Good, M.D, Ph.D., professor of pediatrics and distinguished research professor at the University of South Florida College of Medicine and physician-in-chief at All Children’s Hospital in St. Petersburg, gave the E. Donnall Thomas Lecture. In 1968 Good performed the first successful allogeneic bone marrow transplant, carried out for an infant with severe combined immunodeficiency.

Slamon Appointed

President Clinton has announced that he will appoint Dennis Slamon, M.D., Ph.D., to the President’s Cancer Panel.

Slamon is the director for clinical and translational research and director of the Revlon/UCLA Women’s Cancer Research Program at the University of California at Los Angeles Jonsson Comprehensive Cancer Center.

Slamon will replace Paul Calabresi, M.D., director of the Brown-Tufts Cancer Center, on the panel, which monitors the development and execution of National Cancer Program activities. He will serve a 3-year term.

Two Named at Chicago

The University of Chicago Section of Hematology/Oncology has named Wendy Stock, M.D., director of the Leukemia Program, and Richard A. Larson, M.D., director of Hematology Research.

Stock is an established translational researcher in leukemia, lymphoma, and hematologic malignancies. She previously served as director of the Clinical Hematologic Malignancy Program at the University of Illinois-Chicago Medical Center. The appointment is effective Sept. 1.

Larson will continue to have an active role in leukemia research and supervise the expansion of new drug development in hematologic malignancies including leukemia, myeloma, and lymphoma.

Freeman Joins NCI

Harold P. Freeman, M.D., has been named the National Cancer Institute’s associate director for reducing health disparities.



View larger version (124K):
[in this window]
[in a new window]
 
Dr. Harold P. Freeman

 
In this position, Freeman will direct the implementation of a plan to reduce cancer-related health disparities and find ways to turn research discoveries into the delivery of services to reduce these disparities.

Freeman serves as chairman of the President’s Cancer Panel. He is also the president and chief executive officer and director of surgery at North General Hospital, New York City.

Burakoff Appointed

Steven J. Burakoff, M.D., has been appointed director of the Kaplan Comprehensive Cancer Center and the Laura and Isaac Perlmutter Professor and director of the Skirball Institute of Biomolecular Medicine at the New York University School of Medicine, effective Sept. 1.



View larger version (127K):
[in this window]
[in a new window]
 
Dr. Steven J. Burakoff

 
Burakoff’s specialties include immunology and translational research in bone marrow transplantation. He is the Margaret M. Dyson Professor of Pediatrics at Harvard Medical School and chairman of the Department of Pediatric Oncology at the Dana Farber Cancer Institute.

Yeager Named

The University of Pittsburgh has named Andrew M. Yeager, M.D., as the director of the Stem Cell Transplantation Program. He also has appointments in the Departments of Medicine and Pediatrics and will direct the Hematopoietic Stem Cell Transplantation Biology Program within the University of Pittsburgh Cancer Institute.



View larger version (105K):
[in this window]
[in a new window]
 
Dr. Andrew M. Yeager

 
Yeager previously directed the Interdisciplinary Stem Cell Biology and Transplantation Program and the Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation at the Emory University School of Medicine.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?